A SynB1-conjugated antibody cocktail crosses the blood–brain barrier to produce a therapeutic effect on rabies
https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c
Proceedings of the National Academy of Sciences, Volume 122, Number 52, December 2025.
ImportanceThe treatment of rabies is limited by the poor ability to penetrate the blood-brain barrier (BBB) and the narrow epitope coverage of existing antibodies. We overcame this fundamental limitation by conjugating a cocktail of three antibodies…
